SCHEMBL2011808

SCHEMBL2011808

CCC=CCCCCCCCCCCCCCC=CC(=O)O

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F7 P08709 5/20 0.58
F3 P13726 5/20 0.58
ALDH1A1 P00352 4/20 0.58
CYP19A1 P11511 4/20 0.58
MAPT P10636 4/20 0.58
PPARA Q07869 4/20 0.58
PTGS1 P23219 3/20 0.58
PPARG P37231 3/20 0.58
KMT2A Q03164 3/20 0.58
PPARD Q03181 3/20 0.58
BLM P54132 3/20 0.58
HSD17B10 Q99714 3/20 0.58
OXER1 Q8TDS5 2/20 0.58
LMNA P02545 2/20 0.58
ALOX15 P16050 2/20 0.58
RECQL P46063 2/20 0.58
KDM4E B2RXH2 1/20 0.58
MEN1 O00255 1/20 0.58
FFAR1 O14842 1/20 0.58
NR1I2 O75469 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19693072 1.00 F7 (0.58) F7F3ALDH1A1CYP19A1MAPT
SCHEMBL12612200 1.00 F7 (0.58) F7F3ALDH1A1CYP19A1MAPT
SCHEMBL3970618 1.00 F7 (0.58) F7F3ALDH1A1CYP19A1MAPT
SCHEMBL12612202 1.00 F7 (0.58) F7F3ALDH1A1CYP19A1MAPT
SCHEMBL23698128 1.00 F7 (0.58) F7F3ALDH1A1CYP19A1MAPT
SCHEMBL23698126 1.00 F7 (0.58) F7F3ALDH1A1CYP19A1MAPT
SCHEMBL23698096 1.00 F7 (0.58) F7F3ALDH1A1CYP19A1MAPT
SCHEMBL23698229 1.00 F7 (0.58) F7F3ALDH1A1CYP19A1MAPT
SCHEMBL23698232 1.00 F7 (0.58) F7F3ALDH1A1CYP19A1MAPT
SCHEMBL28102296 1.00 F7 (0.58) F7F3ALDH1A1CYP19A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111278984-B Homo-polymer of fatty acid hydroxide and method for producing the same 国立大学法人京都大学 2023-09-29 CN claimed
CN-113599402-B Semen Platycladi or semen Platycladi extract and application thereof 中国科学院上海药物研究所 2022-06-28 CN claimed
CN-111893142-A Method for producing rare fatty acid using novel enzyme and novel rare fatty acid 国立大学法人京都大学 2020-11-06 CN claimed
CN-107075502-B Method for producing rare fatty acid using novel enzyme and novel rare fatty acid 国立大学法人京都大学 2020-07-10 CN claimed
CN-111278984-A Homopolymers of hydroxylated fatty acids and process for producing the same 国立大学法人京都大学 2020-06-12 CN claimed
CN-107075502-A Method for producing rare fatty acid using novel enzyme and novel rare fatty acid 国立大学法人京都大学 2017-08-18 CN claimed
CN-106456586-A Metabolism-improving agent comprising rare fatty acid 国立大学法人京都大学 2017-02-22 CN claimed
CN-106163511-A Anti-inflammatory agent containing rare fatty acid 国立大学法人京都大学 2016-11-23 CN claimed
CN-103502295-A Composition for one-component polyurethane foams having low free mononmeric MDI content GREENHILL CHEMICAL S A 2014-01-08 CN claimed
CN-103003403-A Recovery and purification of hydroxy fatty acids from source oils LINNAEUS PLANT SCIENCES INC 2013-03-27 CN claimed
CN-111278984-B Homo-polymer of fatty acid hydroxide and method for producing the same 国立大学法人京都大学 2023-09-29 CN disclosed
CN-113599402-B Semen Platycladi or semen Platycladi extract and application thereof 中国科学院上海药物研究所 2022-06-28 CN disclosed
CN-111893142-A Method for producing rare fatty acid using novel enzyme and novel rare fatty acid 国立大学法人京都大学 2020-11-06 CN disclosed
WO-2020203751-A1 PRODUCTION METHOD FOR RARE FATTY ACID USING NOVEL ENZYME, AND NOVEL RARE FATTY ACID 国立大学法人京都大学 2020-10-08 WO disclosed
CN-107075502-B Method for producing rare fatty acid using novel enzyme and novel rare fatty acid 国立大学法人京都大学 2020-07-10 CN disclosed
CN-102459529-A Biofuel consisting of a mixture of naturally occurring fatty acid esters and process for producing the same ARKEMA FRANCE 2012-05-16 CN disclosed
WO-2011075255-A1 UNIFORM FIELD MAGNETIZATION AND TARGETING OF THERAPEUTIC FORMULATIONS THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) 2011-06-23 WO disclosed
US-6342619-B2 REACTING FATTY ACID ESTER HAVING SEGMENT IN WHICH CARBON ONE BEARS HYDROXYL GROUP, CARBON TWO BEARS TWO HYDROGE N ATOMS AND DOUBLE BOND IS BETWEEN CARBONS THREE AND FOUR, WIT H ALKYL OR ARYLSULFONYL CHLORIDE, REACTING WITH DIAZABICYCLOU NDECENE BOEHRINGER INGELHEIM VETMEDICA, INC. 2002-01-29 US disclosed
US-20010049451-A1 Synthesis of conjugated fatty acid BOEHRINGER INGELHEIM VETMEDICA, INC. 2001-12-06 US disclosed
US-6160141-A Synthesis of conjugated eicosadienoic acid MATREYA, INC. 2000-12-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010049451-A1 Synthesis of conjugated fatty acid FASN, LIPC, FADS1 F7 3328/4885F3 2797/4885ALDH1A1 2564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.